Jerry Steffl Joins Prime Therapeutics as Vice President, Government Affairs

ST. PAUL, Minn., June 26 /PRNewswire/ -- Prime Therapeutics (Prime) announced today the hiring of Jerry Steffl as Vice President, Government Affairs. Steffl will be responsible for developing Prime’s position on policy issues at both the national and state levels and coordinating an integrated approach to government affairs both internally and with Prime clients. Steffl will also be responsible for coordinating Prime’s lobbying efforts with industry associations and trade groups, as well as raising Prime’s profile in Washington and in other various states. Steffl began on June 2, and is based in Washington, DC.

“We’re thrilled to be able to add Jerry to our team,” said Matt Yordy, Prime Senior Vice President for Business Development. “He brings with him a wealth of experience in public policy, and a strong understanding of both general healthcare policy as well as more specific pharmacy benefits management (PBM) related issues.”

Prior to joining Prime, Steffl served as Director of Federal Affairs for WellPoint in Washington, DC. He has a Bachelor’s degree in Political Science and Speech Communications from the University of Minnesota.

Prime Therapeutics LLC is a pharmacy benefit management company dedicated to providing innovative, clinically based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 14.6 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and third-party administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at http://www.primetherapeutics.com.

CONTACT: Sheila Thelemann, Sr. Manager, Public Relations and Corporate
Communications of Prime Therapeutics, +1-651-414-1863,
sthelemann@primetherapeutics.com

Web site: http://www.primetherapeutics.com/

MORE ON THIS TOPIC